Corbenic Partners’s InspireMD NSPR Stock Holding History

Corbenic Partners’s Portfolio NSPR Stock Details NSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-333	Closed	-$3K	–	181
2020 Q1	$3K	Buy	+333	New	+$4.81K	﹤0.01%	141

Other funds holding NSPR

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Corbenic Partners's NSPR Position: Q2 2020 in Review

Corbenic Partners sold out of InspireMD (NSPR) in Q2 2020, closing a stake of 333 shares — an estimated $3K sold.

Corbenic Partners first reported a position in NSPR in Q1 2020 and held it in 1 quarter. The position peaked at $3K in Q1 2020. 15 funds tracked by Wall St. Rank hold NSPR as of Q2 2020.

Corbenic Partners reported no remaining InspireMD position as of Q2 2020 after selling out during the quarter.
Corbenic Partners sold 333 InspireMD shares in Q2 2020, an estimated $3K.
Corbenic Partners first reported a position in InspireMD in Q1 2020 and held it in 1 quarter.
Corbenic Partners's InspireMD position peaked at $3K in Q1 2020.
15 funds tracked by Wall St. Rank held InspireMD as of Q2 2020.

Based on Corbenic Partners's 13F filing for Q2 2020, filed 17 Jul 2020.